BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24148247)

  • 1. miR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma.
    Liu M; Wang J; Huang H; Hou J; Zhang B; Wang A
    Biochem Biophys Res Commun; 2013 Nov; 441(2):364-70. PubMed ID: 24148247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist.
    Peng F; Zhang H; Du Y; Tan P
    Oncol Rep; 2015 Feb; 33(2):942-50. PubMed ID: 25501015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
    Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J
    Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer.
    Wang X; Guo H; Yao B; Helms J
    Oncol Rep; 2017 May; 37(5):2720-2726. PubMed ID: 28350138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-940 inhibits migration and invasion of tongue squamous cell carcinoma via regulatingCXCR2/NF-κB system-mediated epithelial-mesenchymal transition.
    Ma T; Zhao Z; Wang Z; Wang C; Zhang L
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1359-1369. PubMed ID: 31214736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic gene RGC-32 is a direct target of miR-26b and facilitates tongue squamous cell carcinoma aggressiveness through EMT and PI3K/AKT signalling.
    Yang ZH; Li J; Chen WZ; Kong FS
    Cell Biochem Funct; 2020 Oct; 38(7):943-954. PubMed ID: 32325539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.
    Li D; Liu K; Li Z; Wang J; Wang X
    Cell Adh Migr; 2018 May; 12(3):236-246. PubMed ID: 29130787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin.
    Zhu X; Shen H; Yin X; Long L; Xie C; Liu Y; Hui L; Lin X; Fang Y; Cao Y; Xu Y; Li M; Xu W; Li Y
    Oncogene; 2016 Jan; 35(3):323-32. PubMed ID: 25867064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNHG1/miR-194-5p/MTFR1 Axis Promotes TGFβ1-Induced EMT, Migration and Invasion of Tongue Squamous Cell Carcinoma Cells.
    Jia Y; Chen X; Zhao D; Ma S
    Mol Biotechnol; 2022 Jul; 64(7):780-790. PubMed ID: 35107755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA LTSCCAT promotes tongue squamous cell carcinoma metastasis via targeting the miR-103a-2-5p/SMYD3/TWIST1 axis.
    Liu M; Liu Q; Fan S; Su F; Jiang C; Cai G; Wang Y; Liao G; Lei X; Chen W; Bi J; Cheng W; Zhao L; Ruan Y; Li J
    Cell Death Dis; 2021 Feb; 12(2):144. PubMed ID: 33542221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma.
    Lin XJ; He CL; Sun T; Duan XJ; Sun Y; Xiong SJ
    Int J Mol Med; 2017 Jul; 40(1):83-89. PubMed ID: 28535002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
    Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
    Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
    Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
    Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT).
    Jiao J; Zhao X; Liang Y; Tang D; Pan C
    Biochem Biophys Res Commun; 2015 Oct; 466(3):327-32. PubMed ID: 26362179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1.
    Liu W; Zhang B; Xu N; Wang MJ; Liu Q
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3787-3793. PubMed ID: 28975990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation.
    Chen W; Wang P; Lu Y; Jin T; Lei X; Liu M; Zhuang P; Liao J; Lin Z; Li B; Peng Y; Pan G; Lv X; Zhang H; Ou Z; Xie S; Lin X; Sun S; Ferrone S; Tannous BA; Ruan Y; Li J; Fan S
    Theranostics; 2019; 9(20):5739-5754. PubMed ID: 31534516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells.
    Li H; Zhang P; Sun X; Sun Y; Shi C; Liu H; Liu X
    Int J Oncol; 2015 Oct; 47(4):1379-92. PubMed ID: 26323677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.